Viome Stock

www.viome.comHealthcare / Healthcare providers & servicesFounded: 2016Funding to Date: $183.09MM

Viome is a direct-to-consumer healthcare company, predicting and preventing chronic diseases through a deeper understanding of an individual's biology at a molecular level. The company analyzes microbial and human gene expressions (mRNA), with technology to provide individuals with health insights and precision nutrition.

Register for Details

For more details on financing and valuation for Viome, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Viome.

Register Today

Other companies like Viome in the Healthcare providers & services sector

Sector
Last Round Est. Valuation
$648.94MM
Sector
Last Round Est. Valuation
$1.65B
Sector
Last Round Est. Valuation
$1.39B
Sector
Last Round Est. Valuation
$5.7B
Sector
Last Round Est. Valuation
$37.8MM
Sector
Last Round Est. Valuation
$1.81B
Sector
Last Round Est. Valuation
$3.52B
Sector
Last Round Est. Valuation
$1.53B
Sector
Last Round Est. Valuation
$6.22B

News Highlights

Viome Life Sciences Announces $67 Million in Funding towards Series C Financing Round
Viome Life Sciences, a mission-driven, digital health company leveraging precision nutrition to increase health and longevity, announces today additional funding toward its series C financing round.
Updated on: Sep 30, 2023